Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1962092

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1962092

Global Infection Surveillance Solutions Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The Infection Surveillance Solutions Market size is expected to reach USD 2360.89 Million in 2034 from USD 755.29 Million (2025) growing at a CAGR of 13.5% during 2026-2034.

The infection surveillance solutions market is poised for significant growth, driven by the increasing need for effective infection control and prevention strategies in healthcare settings. As the global burden of healthcare-associated infections (HAIs) continues to rise, healthcare facilities are prioritizing the implementation of robust surveillance systems to monitor and manage infection outbreaks. These solutions enable healthcare providers to collect, analyze, and report data on infection rates, facilitating timely interventions and improving patient safety. Innovations in data analytics, artificial intelligence, and machine learning are enhancing the capabilities of infection surveillance systems, allowing for real-time monitoring and predictive analytics that can identify potential outbreaks before they escalate.

Moreover, the growing emphasis on regulatory compliance and quality improvement initiatives is influencing the infection surveillance solutions market. Healthcare organizations are increasingly required to adhere to stringent guidelines and reporting standards set by regulatory bodies, driving the demand for comprehensive surveillance solutions that ensure compliance. Additionally, the rise of value-based care models is prompting healthcare providers to focus on improving patient outcomes and reducing costs associated with infections, further fueling the adoption of infection surveillance technologies.

Furthermore, the COVID-19 pandemic has underscored the importance of infection surveillance in managing public health crises. The need for effective tracking and reporting of infectious diseases has led to increased investments in surveillance technologies, not only in hospitals but also in public health agencies. The integration of mobile health applications and telehealth platforms is also enhancing the accessibility and efficiency of infection surveillance solutions, enabling healthcare providers to monitor infections in real-time and respond swiftly to emerging threats. In summary, the infection surveillance solutions market is set for robust growth, characterized by technological advancements, a focus on regulatory compliance, and a commitment to improving patient safety and public health.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products and Services

  • Software
  • Services

By Infection Type

  • Surgical Site Infections
  • Blood Stream Infections
  • Urinary Tract Infections

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

COMPANIES PROFILED

  • Becton, Dickinson and Company BD, , Premier, Inc, Wolters Kluwer NV, Cerner Corporation Oracle, RLDatix, VigiLanz Corporation, GOJO Industries, Inc, Baxter International Inc, bioMrieux SA, IBM Corporation Merative, Epic Systems Corporation, Theradoc Premier Inc, bioVigil Healthcare Systems, Inc, Ecolab Inc, Asolva, Inc

We can customise the report as per your requriements

Product Code: VMR112115391

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY PRODUCTS AND SERVICES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Products And Services
  • 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY INFECTION TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Infection Type
  • 5.2. Surgical Site Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Blood Stream Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Urinary Tract Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Products And Services
    • 7.2.2 By Infection Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Products And Services
    • 7.3.2 By Infection Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Products And Services
    • 7.4.2 By Infection Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Products And Services
    • 7.5.2 By Infection Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Products And Services
    • 7.6.2 By Infection Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INFECTION SURVEILLANCE SOLUTIONS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 PremierInc
    • 9.2.2 Wolters Kluwer N.V
    • 9.2.3 Cerner Corporation (Oracle)
    • 9.2.4 RLDatix
    • 9.2.5 VigiLanz Corporation
    • 9.2.6 GOJO IndustriesInc
    • 9.2.7 Baxter International Inc
    • 9.2.8 BioMAfA(C)Rieux SA
    • 9.2.9 IBM Corporation (Merative)
    • 9.2.10 Epic Systems Corporation
    • 9.2.11 Theradoc (Premier Inc.)
    • 9.2.12 BioVigil Healthcare SystemsInc
    • 9.2.13 Ecolab Inc
    • 9.2.14 AsolvaInc
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!